Azole-echinocandin Combination Therapy for Invasive Aspergillosis

NCT04876716 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

66

Enrollment

OTHER

Sponsor class

Stopped futility

Conditions

Invasive Aspergillosis

Interventions

DRUG: Azole
DRUG: Anidulafungin

Sponsor

Erasmus Medical Center

Collaborators

[object Object]
[object Object]